ArticleNature communications2025

Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2.

Candice Sakref et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.